title: Decoding the substrate supply to human neuronal nitric oxide synthase.
abstract: Nitric oxide, produced by the neuronal nitric oxide synthase (nNOS) from L-arginine is an important second messenger molecule in the central nervous system: It influences the synthesis and release of neurotransmitters and plays an important role in long-term potentiation, long-term depression and neuroendocrine secretion. However, under certain pathological conditions such as Alzheimer's or Parkinson's disease, stroke and multiple sclerosis, excessive NO production can lead to tissue damage. It is thus desirable to control NO production in these situations. So far, little is known about the substrate supply to human nNOS as a determinant of its activity. Measuring bioactive NO via cGMP formation in reporter cells, we demonstrate here that nNOS in both, human A673 neuroepithelioma and TGW-nu-I neuroblastoma cells can be fast and efficiently nourished by extracellular arginine that enters the cells via membrane transporters (pool I that is freely exchangeable with the extracellular space). When this pool was depleted, NO synthesis was partially sustained by intracellular arginine sources not freely exchangeable with the extracellular space (pool II). Protein breakdown made up by far the largest part of pool II in both cell types. In contrast, citrulline to arginine conversion maintained NO synthesis only in TGW-nu-I neuroblastoma, but not A673 neuroepithelioma cells. Histidine mimicked the effect of protease inhibitors causing an almost complete nNOS inhibition in cells incubated additionally in lysine that depletes the exchangeable arginine pool. Our results identify new ways to modulate nNOS activity by modifying its substrate supply.
authors.affiliation: Department of Pharmacology, University Medical Centre of the Johannes Gutenberg University, Mainz, Germany.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Simon
authors.forename: Susanne
authors.initials: S
authors.lastname: Karbach
authors.forename: Alice
authors.initials: A
authors.lastname: Habermeier
authors.forename: Ellen I
authors.initials: EI
authors.lastname: Closs
mesh_terms: D001120:Arginine / Q000378:metabolism / Q000494:pharmacology; D002460:Cell Line; D002956:Citrulline / Q000378:metabolism; D004789:Enzyme Activation / Q000187:drug effects; D005110:Extracellular Space / Q000378:metabolism; D006801:Humans; D008247:Lysosomes / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism; D009474:Neurons / Q000378:metabolism*; D009569:Nitric Oxide / Q000096:biosynthesis; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism*; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D059748:Proteolysis; D013379:Substrate Specificity
chemical_list: D002956:Citrulline; D009569:Nitric Oxide; D001120:Arginine; D052248:Nitric Oxide Synthase Type I; D046988:Proteasome Endopeptidase Complex